Lime Chemicals appoints Samir Kumar Das as new Board Chairman
Lime Chemicals Limited replaced Chairman Avinash Jhaveri with Samir Kumar Das on August 04, 2026. Das, an Insolvency Professional with BFSI experience, now chairs the Audit Committee. Rakhi Jayantilal Upadhyay was also appointed as an Independent Director. The board reconstituted the Audit, Nomination, Stakeholders Grievance, and Risk Management Committees to align with these changes under SEBI Listing Regulations.

*this image is generated using AI for illustrative purposes only.
Lime Chemicals Limited has reshuffled its Board of Directors following the resignation of Mr. Avinash Jhaveri, who served as the Non-Executive Independent Director designated as Chairman. The resignation, effective August 04, 2026, was submitted to concentrate on personal commitments, with no other material reasons disclosed. In response, the Board appointed Mr. Samir Kumar Das as the new Non-Executive Independent Director designated as Chairman of the Board on the same date. Additionally, Ms. Rakhi Jayantilal Upadhyay was appointed as a Non-Executive Independent Director.
These appointments were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Part A of Schedule III of the Listing Regulations and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The Board meeting held on August 04, 2026, formalized these changes and subsequently reconstituted four key statutory committees to reflect the new directorial lineup.
Mr. Samir Kumar Das brings over 30 years of leadership experience from top BFSI institutions, including SBI, ICICI Bank, Axis Bank, Tata Capital, and Aditya Birla Finance. As an Insolvency Professional, he specializes in governance, corporate and SME risk management, stressed asset resolution, and compliance oversight under the Insolvency & Bankruptcy Code. He currently serves as a Non-Executive Independent Director at Monika Alcobev Limited. Ms. Rakhi Jayantilal Upadhyay contributes more than 25 years of experience as a Financial Consultant, focusing on due diligence and verification.
The reconstitution of the committees is detailed below:
Committee Reconstitution
Audit Committee
| Member Name | Designation |
|---|---|
| Samir Kumar Das | Chairman – Non-Executive Independent |
| Ahmed H. Dawoodani | Member – Executive |
| Rakhi Upadhyay | Member – Non-Executive Independent |
Nomination and Remuneration Committee
| Member Name | Designation |
|---|---|
| Rakhi Upadhyay | Chairperson – Non-Executive Independent |
| Rahim Narsingdani | Member – Non-Executive Independent |
| Samir Kumar Das | Member – Non-Executive Independent |
Stakeholders Grievance Committee
| Member Name | Designation |
|---|---|
| Shahnaz A. Dawoodani | Chairperson – Non-Executive non-Independent |
| Ahmed H. Dawoodani | Member – Executive |
| Rahim Narsingdani | Member – Non-Executive Independent |
Risk Management Committee
| Member Name | Designation |
|---|---|
| Rahim Narsingdani | Chairman – Non-Executive Independent |
| Ahmed H. Dawoodani | Member – Executive |
| Shahnaz A. Dawoodani | Member – Non-Executive non Independent |
Governance Implications
The departure of Mr. Jhaveri marks a leadership transition for Lime Chemicals Limited, which has maintained over five decades of manufacturing excellence in calcium carbonate. Mr. Jhaveri confirmed that he holds no other directorships in listed companies. Both incoming directors, Mr. Das and Ms. Upadhyay, have confirmed they are not related to any Director, Promoter, or Promoter Group of the Company and are not debarred from holding office. The structural shift places significant emphasis on financial expertise and insolvency resolution within the Board’s governance framework, particularly through Mr. Das’s chairmanship of the Audit Committee.
Historical Stock Returns for Lime Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.50% | +5.13% | -3.93% | +7.57% | -20.40% | -45.69% |
How might Mr. Samir Kumar Das's extensive background in insolvency resolution and stressed asset management influence Lime Chemicals' approach to financial risk and capital allocation?
What impact could the shift in Audit Committee leadership have on the company's financial reporting standards and regulatory compliance posture?
Given the new Board's strong emphasis on BFSI expertise, are there indications of potential strategic shifts in Lime Chemicals' financing strategies or debt restructuring plans?


































